MAP2K3 and colorectal carcinoma: Our data demonstrated that AT9283 abrogated MKK3 functions mainly through AURKA inhibition highlighting the relevance of the MKK3/AURKA crosstalk in sustaining CRC malignancy, and provide novel insights on the regulatory network between these two proteins in CRC.